drugset / Trial / NCT01270152
Determining the Safe Dosage of Ascorbic Acid Used in the Treatment of Occluded Totally Implanted Central Venous Catheter
RandomizedParallel-groupOpen-label
Summary
The hypothesis of the study is to evaluate whether ascorbic acid is able to clear totally implanted central venous catheter
Timeline
- Start
- 2008-10
- Primary completion
- 2009-12
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vitamin C | Other / unclassified | 50 mg | Other |
| Subject | Vitamin C | Other / unclassified | 100 mg | Other |
| Subject | Vitamin C | Other / unclassified | 200 mg | Other |
Indications
No indication recorded.